Precision Treatment of Advanced Lung Adenocarcinoma With Coexisting EGFR, ALK, and ROS1 Mutations: A Case Report. Zhang Y, Wang H, Wang X, Li S, et al. Clin Lung Cancer 2021;22:e699-e702.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang Y, Wang H, Wang X, Li S, et al. Precision Treatment of Advanced Lung Adenocarcinoma With Coexisting EGFR, ALK, and ROS1 Mutations: A Case Report. Clin Lung Cancer 2021;22:e699-e702.
PMID: 33640300